Enzymatic assays for a droplet actuator
    5.
    发明公开
    Enzymatic assays for a droplet actuator 审中-公开
    Enzymassaysfüreinen Tropfenaktuator

    公开(公告)号:EP2837692A1

    公开(公告)日:2015-02-18

    申请号:EP14186092.4

    申请日:2008-03-23

    IPC分类号: C12Q1/34 B01F13/08 C07H15/04

    摘要: A method of conducting a droplet-based enzymatic assay is provided. The method generally makes use of a droplet actuator. A droplet comprising an enzyme of interest is provided on the droplet actuator along with a droplet comprising a substrate which is potentially modified in the presence of the enzyme. The method involves executing droplet operations on the droplet actuator to combine the droplets, thereby yielding an assay droplet, and detecting modification of the substrate by the enzyme in the assay droplet on the droplet actuator. The enzyme of interest may, for example, be a potentially mutated or improperly folded enzyme exhibiting altered enzyme activity as compared to a corresponding normal enzyme.

    摘要翻译: 提供了一种进行基于液滴的酶测定的方法。 该方法通常使用液滴致动器。 包含感兴趣的酶的液滴与包含底物的液滴一起提供在液滴致动器上,该底物在酶的存在下可能被修饰。 该方法涉及在液滴致动器上执行液滴操作以组合液滴,从而产生测定液滴,并且通过液滴致动器上的测定液滴中的酶检测底物的修饰。 感兴趣的酶可以是例如与相应的正常酶相比显示出酶活性变化的潜在的突变或不正确折叠的酶。

    AMPLIFICATION PRIMERS AND PROBES FOR DETECTION OF HIV-1
    6.
    发明公开
    AMPLIFICATION PRIMERS AND PROBES FOR DETECTION OF HIV-1 审中-公开
    扩增和探针HIV-1的检测

    公开(公告)号:EP2809784A1

    公开(公告)日:2014-12-10

    申请号:EP13742978.3

    申请日:2013-01-22

    发明人: LEITNER, Thomas

    IPC分类号: C12N15/11 C12Q1/68

    CPC分类号: C12Q1/703 C12Q2600/112

    摘要: The present invention relates to amplification oligonucleotides (primers) and detection probes for the detection of human immunodeficiency virus type-1 (HIV-1) in a test sample. The primers and probes may be used in an assay for the detection and/or quantitation of HIV-1 nucleic acid. In various embodiments, the primers and detection probes may be used for real-time reverse transcription polymerase chain reaction (RT-PCR) assays for detection of HIV-1 nucleic acid. The detection probes may, for example, be fluorescently-labeled TaqMan® probes. In one embodiment, amplification primers and probes may be specific for the pol region of the HIV-1 genome. In another embodiment, the amplification primers and probes may be specific for the env region of the HIV-1 genome. "Cocktails" of multiple amplification primers and/or probes may be used to achieve maximal coverage of different HIV-1 subtypes.